Treatment Patterns and Outcomes of Stage III Non-Small Cell Lung Cancer (NSCLC): Real World Evidence of How our Patients Fare

被引：1

作者：

Yusuf, D. ^{[1
]}

Walton, R. ^{[2
]}

Hurry, M. ^{[2
]}

Cheung, W. ^{[3
,4
]}

机构：

[1] Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada

[2] Astrazeneca Canada, Mississauga, ON, Canada

[3] Univ Calgary, Med, Calgary, AB, Canada

[4] Alberta Hlth Serv, Calgary, AB, Canada

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

outcomes; Treatments; NSCLC;

D O I：

10.1016/j.jtho.2018.08.967

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.15-34

引用

页码：S626 / S626

页数：1

共 50 条

[41] Treatment Patterns and Clinical Practices of Advanced (Stage IV) Non-Small Cell Lung Cancer (NSCLC) in Europe - A Structured Literature Review
Brodowicz, Thomas
Niepel, Daniela
Booth, Emma
Hernandez, Rohini K.
Braileanu, George
Cawkwell, Marie
Amelio, Justyna
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S676 - S676
[42] Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre
Fletcher, J.
Mullally, W. J.
Berman, C.
Ladwa, R.
Xu, W.
O'Byrne, K.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S628 - S629
[43] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
Christian Manegold
Petr Zatloukal
Kurt Krejcy
Johannes Blatter
Investigational New Drugs, 2000, 18 : 29 - 42
[44] ADVANCED NON-SMALL CELL LUNG (NSCLC) IN YOUNG PATIENTS (≤ 40 YEARS): TREATMENT AND CLINICAL OUTCOMES
Caffo, Orazio
Ceribelli, Anna
Demarinis, Filippo
Gregore, Vanesa
Novello, Silvia
Bearz, Alessandra
Bonetti, Andrea
Grossi, Francesco
Murgia, Viviana
Ricciardi, Serena
Rosetti, Francesco
Tiseo, Marcello
Vavala, Tiziana
Galligioni, Enzo
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1223 - S1224
[45] Radiation therapy of stage I and II non-small cell lung cancer (NSCLC)
Zierhut, D
Bettscheider, C
Schubert, K
van Kampen, M
Wannenmacher, M
LUNG CANCER, 2001, 34 : S39 - S43
[46] Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer
Stevens, Samuel
Nindra, Udit
Shahnam, Adel
Wei, Joe
Bray, Victoria
Pal, Abhijit
Yip, Po Yee
Linton, Anthony
Blinman, Prunella
Nagrial, Adnan
Lee, Jenny
Boyer, Michael
Kao, Steven
JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (02)
[47] Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis
Carroll, Robert
Bortolini, Margherita
Calleja, Alan
Munro, Robin
Kong, Shiying
Daumont, Melinda J.
Penrod, John R.
Lakhdari, Khalid
Lacoin, Laure
Cheung, Winson Y.
BMC CANCER, 2022, 22 (01)
[48] Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice
Dickson, Natalie R.
Beauchamp, Karen D.
Perry, Toni S.
Roush, Ashley
Goldschmidt, Deborah
Edwards, Marie Louise
Blakely, Laura J.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (08) : 609 - 619
[49] Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NSCLC)
Liu, Jason
Bratton, Emily
Yu, Xinyan
Ladbury, Colton
Wagner, Joseph
West, Howard
Massarelli, Erminia
Salgia, Ravi
Pathak, Ranjan
Villaflor, Victoria
Villalona-Calero, Miguel
Amini, Arya
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (02): : 49 - 54
[50] EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes
Xu, Haiyan
Yang, Guangjian
Li, Weihua
Li, Junling
Hao, Xuezhi
Xing, Puyuan
Yang, Yaning
Wang, Yan
FRONTIERS IN ONCOLOGY, 2021, 11

← 1 2 3 4 5 →